- Home
- Services
- north america
- diagnostics introduces fluorometric neuraminidase assay
Show results for
Refine by
Diagnostics Introduces Fluorometric Neuraminidase Assay Services In North America
6 services found
by:NanoPin Technologies Inc. based inNew Orleans, LOUISIANA (USA)
NanoPin has proprietary intellectual property for its diagnostic platform, methods, and applications. We are committed to enhancing our IP as we work with our partners to provide advanced diagnostic assays in the USA and globally. ...
Manufactured by:Vela Diagnostics USA Inc. based inFairfield, NEW JERSEY (USA)
The Vela Diagnostics Technical Support team is committed to augmenting customer productivity by providing superior technical and application support with internal and field based personnel. We strive to provide the highest level of service to achieve maximum customer satisfaction. ...
by:NanoPin Technologies Inc. based inNew Orleans, LOUISIANA (USA)
NanoPin assays can detect extremely low levels of active disease elements (antigen peptides) in blood samples. This is a critical differentiator with other diagnostic assays which can not distinguish between latent and active ...
by:PathAI, Inc. based inBoston, MASSACHUSETTS (USA)
Rapidly advance your precision medicine strategy and move seamlessly from development to commercial launch with bespoke diagnostic assays and AI-powered companion ...
Manufactured by:Avioq, Inc. based inResearch Triangle Park, NORTH CAROLINA (USA)
Avioq, a trusted clinical diagnostics company, has developed a broad line of diagnostics in-vitro assays for the clinical lab. With this experience, we offer extensive contract development and manufacturing ...
by:Auspex Diagnostics based inWarren, NEW JERSEY (USA)
Auspex Diagnostic’s colorectal cancer test is a revolutionary treatment planning tool that can help stage II and III colorectal cancer patients and doctors personalize the treatment to the individual patient’s genes. Since no two patients are the alike, it is crucial that patients learn as much as possible about their tumor to determine the most suitable treatment plan. The test ...